MetLife (MET)

NYSE Financials Life & Health Insurance S&P 500
$98.27
-1.48 (-1.48%)
Close of Nov 06, 2026 · end-of-day data
Source: MetLife's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$60.79B$62.31B$1.26B$1.29B$1.35B$2.07B$2.11B$2.23B$2.25B$2.44B
Operating income——————$5.98B$5.72B$6.00B$6.14B
Interest expense$874.00M$841.00M$827.00M$656.00M$632.00M$647.00M$655.00M$740.00M$738.00M$724.00M
Pre-tax income$4.28B$3.54B$6.31B$6.79B$6.93B$8.52B$6.36B$2.16B$5.62B$4.66B
Income tax$693.00M-$1.47B$1.18B$886.00M$1.51B$1.64B$1.06B$560.00M$1.18B$1.26B
Net income$850.00M$4.01B$5.12B$5.90B$5.41B$6.86B$5.28B$1.58B$4.43B$3.38B
EBITDA——————$6.10B$5.83B$6.12B$6.25B
EPS (basic)$0.68$3.65$4.95$6.10$5.72$7.71$6.35$1.82$5.98$4.74
EPS (diluted)$0.67$3.62$4.91$6.06$5.68$7.65$6.30$1.81$5.94$4.71
Diluted shares1.11B1.08B1.01B944.40M913.20M869.40M808.90M762.30M711.10M673.30M
Operating margin——————283.3%256.8%267.1%251.9%
Net margin1.4%6.4%407.9%457.6%399.3%330.5%250.4%70.8%197.1%138.7%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$12.65B$12.70B$15.82B$16.60B$19.80B$20.05B$20.20B$20.64B$20.07B$22.03B
Short-term investments$6.52B$4.87B$3.94B$3.85B$3.90B$7.18B$4.93B$6.04B$5.16B$3.60B
Goodwill$9.22B$9.59B$9.42B$9.31B$10.11B$9.54B$9.30B$9.24B$8.90B$9.61B
Total assets$898.76B$719.89B$687.54B$740.46B$795.15B$759.71B$663.07B$687.58B$677.46B$745.17B
Short-term debt$242.00M$477.00M$268.00M$235.00M$393.00M$341.00M$175.00M$119.00M$465.00M$355.00M
Total debt$242.00M$477.00M$268.00M$235.00M$393.00M$341.00M$175.00M$119.00M$465.00M$355.00M
Total liabilities$831.06B$661.02B$634.58B$674.08B$720.33B$691.96B$632.95B$657.33B$649.75B$716.25B
Shareholders' equity$67.53B$58.68B$52.74B$66.14B$74.56B$67.48B$29.88B$30.02B$27.45B$28.40B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$14.77B$12.28B$11.74B$13.79B$11.64B$12.35B$13.04B$13.72B$14.60B$17.09B
Free cash flow$14.77B$12.28B$11.74B$13.79B$11.64B$12.35B$13.04B$13.72B$14.60B$17.09B
Investing cash flow-$5.85B-$16.88B-$5.63B-$17.59B-$18.57B-$11.19B-$2.62B-$10.25B-$11.49B-$15.61B
Financing cash flow-$3.50B-$906.00M-$2.80B$4.57B$10.73B-$1.13B-$9.95B-$2.94B-$3.13B$163.00M
Dividends paid$1.74B$1.72B$1.68B$1.64B$1.66B$1.65B$1.60B$1.57B$1.53B$1.51B
Share buybacks$372.00M$2.93B$3.99B$2.29B$1.15B$4.30B$3.33B$3.10B$3.21B$2.88B
Stock-based compensation$147.00M$128.00M$86.00M$150.00M$127.00M$173.00M$184.00M$171.00M$168.00M$131.00M
Depreciation & amortization$206.00M$207.00M$191.00M$207.00M$194.00M$123.00M$118.00M$112.00M$124.00M$117.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.